Tech Company Financing Transactions
Xontogeny Funding Round
Perceptive Advisors invested in a $25 million Series A capital raise for Xontogeny. The round was recorded on 5/19/2017.
Transaction Overview
Company Name
Announced On
5/19/2017
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series A
Investors
Perceptive Advisors (Joseph Edelman)
Proceeds Purpose
Xontogeny intends to use the proceeds from this financing to manage operations, build its team of experts, and advance early stage development of life science products in its portfolio companies.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
75 Arlington St. 5th Floor 5005
Boston, MA 02116
USA
Boston, MA 02116
USA
Phone
Undisclosed
Website
Email Address
Overview
Xontogeny is a biotech aggregator with a differentiated business model to support the accelerated development of life science technologies in the pursuit of helping patients with serious diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Chris Garabedian
VP - Bus. Development
Fred Callori
Browse more venture capital transactions:
Prev: 5/19/2017: WISErg venture capital transaction
Next: 5/19/2017: Information Builders venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on funding rounds that are announced publicly. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs